trovafloxacin


Also found in: Wikipedia.

trovafloxacin

 [tro″vah-flok´sah-sin]
an antibacterial effective against a broad spectrum of gram-positive and gram-negative organisms; administered orally as the mesylate salt in the treatment of serious infections.

trovafloxacin

/tro·va·flox·a·cin/ (tro″vah-flok´sah-sin) an antibacterial effective against a broad spectrum of gram-positive and gram-negative organisms; used as the mesylate salt.

trovafloxacin

[tro′vah-flok′sah-sin]
an antibacterial effective against a broad spectrum of gram-positive and gram-negative organisms. It is administered orally as the mesylate salt in the treatment of serious infections.

trovafloxacin

a fluoroquinolone antibiotic with activity against anaerobic bacteria.
References in periodicals archive ?
section]) Per 10% increase in fluoroquinolone prescribing during the previous year; includes ciprofloxacin, gemifloxacin, levofloxacin, moxifloxacin, norfloxacin, ofloxacin, and trovafloxacin.
Novel a1-adrenoceptor antagonism by the fluroquinolone antibiotic trovafloxacin.
Phenotypic resistance of staphylococcus aureus, selected enterobacteriaceae, and pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.
Trovafloxacin received a black box warning from the FDA in 1998 (Mandell and Tillotson, 2002) costing Pfizer $8.
Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichiacoli in an in vitro dynamic model.
Other fluoroquinolones such as gemifloxacin, sparfloxacin, grepafloxacin, trovafloxacin, and garenoxacin have been shown to be effective against M.
A recent example is the trial using the antibiotic trovafloxacin, administered orally, versus Food and Drug Administration-approved parenteral ceftriaxone, during a meningitis outbreak in Nigeria (N.
There was no means of enforcing ethical practices in health research in Nigeria until recent developments following the negative publicity that resulted from testing of the drug trovafloxacin (Trovan) by the drug company Pfizer during a bacterial (meningococcal) meningitis epidemic in Tudun Wada, Kano, Northern Nigeria, in 1996.
troglitazone, bromfenac, pemoline, tolcapone, trovafloxacin and benoxaprofen [4].
Food and Drug Administration's ("FDA") approval for the use of Trovafloxacin Mesylate ("Trovan") on children in the U.
In an effort to gain FDA approval for pediatric use of its new antibiotic, trovafloxacin mesylate or Trovan, Pfizer sponsored a study in Kano, Nigeria (Abdullahi v.